BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

MORGAN STANLEY's Holding History (CIK: 0000895421)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,539,000 Value ($000) $1,728 Avg Close — Range —
Q3 2025
Shares 1,539,000 Value ($000) $1,515 Avg Close — Range —
Q2 2025
Shares 1,839,000 Value ($000) $1,712 Avg Close — Range —
Q1 2025
Shares 389,000 Value ($000) $349 Avg Close — Range —
Q4 2024
Shares 4,444,000 Value ($000) $3,791 Avg Close — Range —
Q3 2024
Shares 495,000 Value ($000) $413 Avg Close — Range —
Q1 2024
Shares 2,781,000 Value ($000) $2,265 Avg Close — Range —
Q3 2023
Shares 3,900,000 Value ($000) $2,906 Avg Close — Range —
Q2 2023
Shares 1,400,000 Value ($000) $859 Avg Close — Range —
Q1 2023
Shares 2,100,000 Value ($000) $1,338 Avg Close — Range —
Q4 2022
Shares 1,039,000 Value ($000) $386 Avg Close — Range —
Q3 2022
Shares 1,039,000 Value ($000) $436 Avg Close — Range —
Q2 2022
Shares 3,664,000 Value ($000) $1,467 Avg Close — Range —
Q1 2022
Shares 3,629,000 Value ($000) $1,728 Avg Close — Range —